Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
TOR Signaling in Growth and Metabolism
2006 Standout
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management
2002
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
2011
Inflammation and cancer
2002 StandoutNature
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration
2000
Organ Donors with Malignant Gliomas: An Update
2003
Hepatocellular carcinoma
2018 Standout
Invasion and metastasis of a mammary tumor involves TGF-? signaling
2000
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Epithelial Malignancies in Organ Transplant Patients: Clinical Presentation and New Methods of Treatment
2002
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Calcium signalling: dynamics, homeostasis and remodelling
2003 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
It Takes a Tissue to Make a Tumor: Epigenetics, Cancer and the Microenvironment
2001
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
2000
Synthetic Molecular Motors and Mechanical Machines
2006 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
Smad-dependent and Smad-independent pathways in TGF-β family signalling
2003 StandoutNature
Generic Signals and Specific Outcomes
1999
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Hepatocellular carcinoma
2012 Standout
Combination of a rapamycin analog (CCI‐779) and interferon‐γ is more effective than single agents in treating a mouse model of tuberous sclerosis complex
2006
Cellular survival: a play in three Akts
1999 Standout
Skin Cancers after Organ Transplantation
2003 Standout
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
1999
The versatility and universality of calcium signalling
2000 Standout
TGF- β signaling in cancer – a double-edged sword
2001
Mitochondrial control of cell death
2000 Standout
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
2003 StandoutNobel
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Tuberous sclerosis
2008 Standout
Pre-eclampsia
2010 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
TGFβ in Cancer
2008 Standout
The Functional Role of the Renin–Angiotensin System in Pregnancy and Preeclampsia
2008
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
The basics of epithelial-mesenchymal transition
2009 Standout
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
TGF-β antagonists: Why suppress a tumor suppressor?
2002
The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases
2000
Fibroblasts in cancer
2006 Standout
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Renal cancer: molecular mechanisms and newer therapeutic options
2002
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
2017
The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation
2005
Role of tissue stroma in cancer cell invasion
2003
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Cutaneous Squamous-Cell Carcinoma
2001 Standout
p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration
2002
Regulation of Cell Cycle Progression by Calcium/Calmodulin-Dependent Pathways
2003
Rapamycin Inhibits the Growth and Metastatic Progression of Non-Small Cell Lung Cancer
2004
Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells.
2000
Engineering the ABA Plant Stress Pathway for Regulation of Induced Proximity
2011
Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation
2016
Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
2001 StandoutNobel
Rational design of a split-Cas9 enzyme complex
2015 StandoutNobel
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Cis−Trans Isomerization of Organic Molecules and Biomolecules: Implications and Applications
2003
Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches
2013 StandoutNobel
Artificial Molecular Machines
2015 Standout
TGF-β antagonists: Why suppress a tumor suppressor?
2002
Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells.
2000
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know
2003 Standout
Distinct Signaling Events Downstream of mTOR Cooperate To Mediate the Effects of Amino Acids and Insulin on Initiation Factor 4E-Binding Proteins
2005 StandoutNobel
Ca 2+ -Induced Apoptosis Through Calcineurin Dephosphorylation of BAD
1999 Science
The two faces of transforming growth factor β in carcinogenesis
2003 Standout
Antibodies From Preeclamptic Patients Stimulate Increased Intracellular Ca 2+ Mobilization Through Angiotensin Receptor Activation
2004
Works of Minoru Hojo being referenced
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy1
2002
Lymphocyte intracellular free calcium concentration is increased in preeclampsia
1999
Cyclosporine induces cancer progression by a cell-autonomous mechanism
1999 Nature